Latest / The Demographics Podcast with Fexingo: Aging Populations, Birth Rates, and Economic Impact / How Falling Birth Rates Reshape the Medical Device Industry
Transcript
- Lucas: When we talk about falling birth rates, we usually think about schools shrinking or toy companies struggling. But there's one industry where the demographic shift is quietly driving enormous change: medical devices. Luna: Really? How so? I mean, I get that an older population needs more healthcare, but what's the specific link to devices? Lucas: Consider Japan, which has one of the lowest birth rates in the world. The medical device market there for age-related conditions like joint replacements and cardiac implants has grown by nearly 8 percent annually over the past decade. Meanwhile, sales of pediatric devices like incubators and neonatal monitors are flat or declining. Luna: So companies that used to focus on kids are now pivoting to products for seniors? Lucas: Exactly. Take Medtronic, one of the largest device makers globally. They've been investing heavily in minimally invasive surgical tools for heart disease and chronic pain, and their diabetes division is booming because type 2 diabetes prevalence rises with age. Meanwhile, their portfolio of pediatric-specific devices is shrinking. Luna: That makes sense. But is this shift happening across the board, or just in certain segments? Lucas: It's pretty broad. Orthopedics is a big one. Hip and knee replacements are the most common procedures in the 65-plus age group, and the global market for orthopedic implants is projected to hit over 60 billion dollars by 2030. Companies like Stryker and Zimmer Biomet are designing implants that last longer and require less recovery time, specifically for active older adults. Luna: So the devices themselves are evolving. But what about R&D? Are they actually cutting pediatric research? Lucas: Yeah, some are. A few years ago, Philips announced it was winding down its neonatal monitoring line in certain markets because hospitals weren't buying as many units. Instead, they've ramped up development of home-use devices for seniors, like remote monitoring systems and telehealth platforms. Luna: That's a huge strategic shift. And I imagine it also affects how hospitals budget. If more procedures are for older patients, they might buy fewer surgical tools for kids and more for joint replacements. Lucas: Exactly right. Hospitals are adjusting their capital expenditure. For example, the U.S. is seeing a surge in outpatient orthopedic centers because the demand for joint replacements at ambulatory surgery centers is rising fast. That, in turn, pushes device makers to create instruments that are easier to use in those settings. Luna: And what about hearing aids? That seems like an obvious growth area. Lucas: Absolutely. Hearing loss affects about one in three people over 65, and with the population aging, the market is expected to exceed 10 billion dollars by 2028. Companies like Sonova and Demant are focusing on smart hearing aids that connect to smartphones and can be adjusted via apps. They've reduced their pediatric models significantly. Luna: So basically, the entire product pipeline is being reshaped by demographics. It's not just a matter of selling more of the same stuff to older people; it's a fundamental redesign. Lucas: That's the key point. And it's not just about technology — it's about who the customer is. For instance, in many developing countries where birth rates are still relatively high, pediatric devices remain important. So global companies have to balance portfolios: shrinking in South Korea but growing in Nigeria. Luna: Fascinating. So there's a geographic dimension too. Let's drill into one segment: cardiovascular. How are falling birth rates affecting that? Lucas: Heart disease is age-related, so as the population ages, the number of procedures like stent placements and valve replacements rises. But also, because there are fewer younger people, the overall burden of congenital heart defects — which require interventions early in life — is lower. So companies like Boston Scientific are focusing on transcatheter aortic valve replacement, or TAVR, which is primarily for seniors. Luna: And that's a huge market. But I'm curious about the regulatory side. Does the FDA or other agencies consider demographics when approving devices? Lucas: Not explicitly, but the clinical trials for new devices increasingly enroll older patients because that's the real-world population. In the past, trials might have excluded people over 75. Now, they're the target. So the evidence base is shifting, which then influences how doctors adopt the technology. Luna: That's a subtle but powerful feedback loop. So what does this mean for investors? If you're looking at medical device stocks, should you favor companies with strong geriatric product lines? Lucas: It's a reasonable thesis. Medtronic, Stryker, Boston Scientific — they all have clear aging-focused strategies. On the flip side, companies that are heavily exposed to pediatrics, like certain respiratory device makers, might face headwinds. But it's not a simple bet; you also need to watch for innovation, pricing pressure, and regulatory changes. Luna: Right. And it's worth noting that these trends play out over decades, not quarters. But for this show, we try to spot them early. Lucas: Exactly. And that kind of insight is exactly why we think it's so important to cover these demographic trends. They're not just academic — they shape the products we'll all use as we age. A couple of dollars a month from listeners — buy me a coffee dot com slash fexingo — really helps us keep digging into these stories. Luna: Yeah, it makes a tangible difference. We don't run ads, so listener support is what keeps the podcast ad-free and independent. If you've gotten something out of these episodes, consider tossing a few bucks in the jar. Lucas: Now, let's take this one step further: beyond product lines, how are falling birth rates affecting the labor force in the medical device industry? Fewer young people mean a smaller pool of engineers and technicians. Luna: That's a great point. Are companies struggling to find talent? Lucas: Yes, especially in countries like Japan and Germany. Some device makers are investing heavily in automation and ai assisted design to compensate. Others are relocating R&D to regions with younger workforces, like India or Southeast Asia. So the demographic shift is even reshaping where innovation happens. Luna: So it's not just the customer base that's changing; it's the entire manufacturing and innovation ecosystem. Lucas: Exactly. And the same demographic forces that drive demand for certain devices also constrain supply. That's a double whammy that investors and executives need to navigate. Luna: So we've covered orthopedics, cardiovascular, hearing, and even labor. Any other segment you want to highlight? Lucas: Diabetes. The number of adults over 65 with diabetes is growing fast, and continuous glucose monitors, or CGMs, have become a multi-billion dollar market. Companies like Dexcom and Abbott are benefiting hugely. Interestingly, pediatric CGM use is also rising because of childhood obesity, but the demographic weight is clearly on the older side. Luna: So it's not a complete shift away from kids — there are still some overlapping trends. But the predominant force is aging. Lucas: Right. And the takeaway for our listeners is this: demography is not destiny, but it's a powerful current. Whether you're a healthcare professional, an investor, or just someone thinking about the future, understanding how falling birth rates reshape industries like medical devices can give you a real edge. Luna: Great summary. And if you want to dive deeper, we'll link to some research in the show notes. Lucas: That's it for today. Next episode we'll look at another industry getting remade by demographics. Until then, keep aging gracefully — and keep questioning the trends.